Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
McHutchison J; Sulkowski M; Journal Of Viral Hepatitis, 2008, vol. 15, issue 7, p 475, ISSN 13652893. ISBN 13652893.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef